635 related articles for article (PubMed ID: 19918848)
21. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
[TBL] [Abstract][Full Text] [Related]
23. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
24. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
[TBL] [Abstract][Full Text] [Related]
26. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
[TBL] [Abstract][Full Text] [Related]
27. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer.
Hefler LA; Zeillinger R; Grimm C; Sood AK; Cheng WF; Gadducci A; Tempfer CB; Reinthaller A
Gynecol Oncol; 2006 Nov; 103(2):512-7. PubMed ID: 16750560
[TBL] [Abstract][Full Text] [Related]
30. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
Shariat SF; Roehrborn CG; McConnell JD; Park S; Alam N; Wheeler TM; Slawin KM
J Clin Oncol; 2007 Feb; 25(4):349-55. PubMed ID: 17264329
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
Teknos TN; Cox C; Yoo S; Chepeha DB; Wolf GT; Bradford CR; Carey TE; Fisher SG
Head Neck; 2002 Nov; 24(11):1004-11. PubMed ID: 12410536
[TBL] [Abstract][Full Text] [Related]
32. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
33. The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer.
Alvarez Secord A; Sayer R; Snyder SA; Broadwater G; Rodriguez GC; Berchuck A; Blackwell K
Gynecol Oncol; 2004 Jul; 94(1):74-9. PubMed ID: 15262122
[TBL] [Abstract][Full Text] [Related]
34. Relationships between local and systemic expression of interleukin-12 and plasma levels of vascular endothelial growth factor in patients with gastric cancer.
Nakayama Y; Inoue Y; Nagashima N; Katsuki T; Matsumoto K; Shibao K; Tsurudome K; Hirata K; Sako T; Nagata N; Itoh H
Anticancer Res; 2004; 24(5C):3289-94. PubMed ID: 15515423
[TBL] [Abstract][Full Text] [Related]
35. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
36. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer.
Linderholm BK; Gruvberger-Saal S; Fernö M; Bendahl PO; Malmström P
Breast; 2008 Oct; 17(5):484-91. PubMed ID: 18508268
[TBL] [Abstract][Full Text] [Related]
38. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
[TBL] [Abstract][Full Text] [Related]
39. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
40. [Vascular endothelial growth factor and plasminogen activators in endometrial carcinoma and hyperplasia].
Gerstein ES; Gritsaenko EV; Shcherbakov ME; Shcherbakov AM; Ognerudov NA; Kushlinskiĭ NE
Vopr Onkol; 2003; 49(6):725-9. PubMed ID: 14976916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
